Inventor
Francis Blanche
Inventor
Paris, FR
Overview
Patents· 38 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C12Nprimary
C12NMicroorganisms or enzymes24%
C07KPeptides15%
A61KPreparations for medical, dental or toiletry purposes14%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations12%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms9%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture5%
G01NInvestigating or analysing materials by determining their chemical or physical properties5%
C12RIndexing scheme associated with subclasses c12c - c12q, relating to microorganisms4%
B01DSeparation2%
C07HSugars2%
PatentTitleYear
10,457,739Anti-CEACAM5 antibodies and uses thereof201910,112,991Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide20189,809,653'Anti-LAMP1 antibodies and antibody drug conjugates, and uses thereof'20179,617,345'Anti-CEACAM5 antibodies and uses thereof'20179,493,529'Robo1-Fc fusion protein and use thereof for treating tumours'20169,441,040'Antagonist antibodies and their fab fragments against GPVI and uses thereof'20169,382,312'Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide'20168,852,593'Antagonist antibodies and their fab fragments against GPVI and uses thereof'20148,614,299'Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide'20138,481,487'Modified soluble FGF receptor Fc fusions method'20138,399,636'Purification of a triple helix formation with an immobilized obligonucleotide'20138,119,770'Modified soluble FGF receptor Fc fusions with improved biological activity'20128,017,744'Purification of a triple helix formation with an immobilized oligonucleotide'20117,514,218'Processes for purifying and for detecting target double-stranded DNA sequences by triple helix interaction'20097,202,078'Composition intended for the preservation of infectious recombinant adenoviruses'20077,090,999'Polypeptides involved in the biosynthesis of streptogramins, nucleotide sequences coding for these polypeptides and their use'20067,052,838'Processes for purifying and for detecting target double-stranded DNA sequences by triple helix interaction'20067,038,026'Purification of a triple heli formation with an immobilized oligonucleotide'20066,905,862'Method for producing recombinant adenovirus'20056,833,382'Streptogramins and method for preparing same by mutasynthesis'20046,825,012'DNA molecules, preparation and use in gene therapy'20046,734,008'Composition intended for the preservation of infectious recombinant adenoviruses'20046,670,157'Polypeptides involved in the biosynthesis of streptogramins, nucleotide sequences coding for these polypeptides and their use'20036,656,709'Methods of increasing the production of cobalamins using cob gene expression'20036,649,394'Topoisomerase IV, corresponding nucleotide sequences and uses thereof'20036,537,793'Method of separating viral particles'20036,518,062'Enzyme combinations for destroying proliferative cells'20036,485,958'Method for producing recombinant adenovirus'20026,352,839'Streptogramins for preparing same by mutasynthesis'20026,319,672'Purification of a triple helix formation with an immobilized oligonucleotide'20016,207,150'Variants of thymidine kinase, nucleic acids encoding them, and methods of using them'20016,171,846'Polypeptides involved in the biosynthesis of streptogramins, nucleotide sequences coding for these polypeptides and their use'20016,156,545'Biosynthesis method enabling the preparation of cobalamins'20006,153,597'Pharmaceutical composition useful for nucleic acid transfection, and use thereof'20006,077,699'Polypeptides involved in the biosynthesis of streptogramins, nucleotide sequences coding for these polypeptides and their use'20006,001,631'Topoisomerase IV, corresponding nucleotide sequences and uses thereof'19995,891,695'Polypeptides involved in the biosynthesis of streptogramins, nucleotide sequences coding for these polypeptides and their use'19995,591,614'Process for the enzymatic preparation of macrolactone'1997Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1997–2019Based in Paris, FR· patent location history
2000–2013Patents assigned to AVENTIS PHARMA SA (12)· patent assignee history
2005–2013Patents assigned to CENTELION (7)· patent assignee history
2012–2016Patents assigned to BLANCHE FRANCIS (6)· patent assignee history
2012–2016Patents assigned to CAMERON BEATRICE (6)· patent assignee history
2013–2019Patents assigned to SANOFI SA (9)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| AVENTIS PHARMA SA | 12 | 2000–2013 |
| SANOFI SA | 9 | 2013–2019 |
| CENTELION | 7 | 2005–2013 |
| BLANCHE FRANCISself | 6 | 2012–2016 |
| CAMERON BEATRICE | 6 | 2012–2016 |
Locations
| Location | Patents | Span |
|---|---|---|
| Paris, FR | 38 | 1997–2019 |